Scandinavian Tobacco Group (STG) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
9 Mar, 2026Executive summary
2025 was challenging due to external disruptions, tariffs, and internal operational issues, especially impacting the handmade cigar business in the U.S. and machine-rolled cigars globally, with a focus on protecting market positions and integrating Mac Baren.
The Focus2030 strategy was launched, prioritizing stabilization of core businesses, growth in handmade cigars and nicotine pouches, and improved ROIC, EBIT, and free cash flow over five years.
Despite headwinds, results were broadly in line with revised expectations, with net sales of DKK 9.036 billion and EBITDA margin before special items at 19.8%.
Integration of Mac Baren and SAP/ERP implementation in Europe were key operational focuses, causing temporary disruptions but now resolved.
2026 is positioned as a year of stabilization and investment to support long-term ambitions.
Financial highlights
Net sales: DKK 9.036 billion, down 1.8% year-over-year; Q4 net sales DKK 2.343 billion, down 5%.
EBITDA margin before special items: 19.8% (down from 22.6% in 2024).
Adjusted EPS: DKK 10.8 (down from DKK 13.7 in 2024).
Free cash flow before acquisitions: DKK 595 million, impacted by delayed receivables from ERP rollout; underlying FCF above DKK 800 million.
Net profit for 2025 was DKK 669 million, down from DKK 940 million in 2024.
Outlook and guidance
2026 net sales growth expected at -2% to +2% at constant currencies.
EBIT margin before special items guided at 13–14.5% (vs. 14.9% in 2025).
Free cash flow before acquisitions expected at DKK 950 million–1.2 billion, aided by normalization of working capital.
Adjusted EPS guidance for 2026 is DKK 9–11.
Continued investment in market share and promotional activities expected to pressure margins.
Latest events from Scandinavian Tobacco Group
- Organic sales fell 8.8% in Q1 2025, prompting lower guidance amid US and FX headwinds.STG
Q1 202513 Mar 2026 - Focus2030 targets growth in cigars and nicotine pouches, efficiency, and flexible shareholder returns.STG
CMD 20253 Feb 2026 - Q2 2024 saw 6.3% sales growth, margin gains, and a strategic acquisition for future expansion.STG
Q2 202423 Jan 2026 - Q3 net sales up 7.1% on Mac Baren deal; margin and organic growth declined.STG
Q3 202414 Jan 2026 - Net sales up 5.4% to DKK 9.2bn, but profit down 20.5% amid margin pressure and investments.STG
Q4 202426 Dec 2025 - Record sales, higher dividends, and all board proposals approved amid ongoing strategic investments.STG
AGM 202529 Nov 2025 - Q2 2025 saw flat sales, margin pressure, and guidance reaffirmed despite organic decline.STG
Q2 202523 Nov 2025 - Q3 2025 organic sales rose 0.3% with margin recovery and narrowed full-year guidance.STG
Q3 202512 Nov 2025